Hydroxycarbamide/imiquimodVarious toxicities : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1957卷 / 1期

关键词：

D O I：

10.1007/s40278-023-39410-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：285 / 285

相关论文

共 50 条

[21] Dasatinib/hydroxycarbamide/imatinibVarious toxicities, lack of efficacy and drug resistance: case report
Reactions Weekly, 2022, 1887 (1) : 248 - 248
[22] Hydroxycarbamide/imatinibVarious toxicities: 2 case reports
Reactions Weekly, 2020, 1833 (1) : 195 - 195
[23] Hydroxycarbamide/ruxolitinibBasalioma: case report
Reactions Weekly, 2017, 1675 (1) : 130 - 130
[24] Hydroxycarbamide/imatinibLack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 245 - 245
[25] Hydroxycarbamide/sorafenibTreatment failure: case report
Reactions Weekly, 2022, 1891 (1) : 160 - 160
[26] Hydroxycarbamide overdoseMyelosuppression in a child: case report
Reactions Weekly, 2012, 1413 (1) : 25 - 25
[27] Hydroxycarbamide/voxelotorVenous thromboembolism : case report
Reactions Weekly, 2022, 1907 (1) : 240 - 240
[28] Hydroxycarbamide/rasburicaseLack of efficacy: case report
Reactions Weekly, 2024, 2023 (1) : 192 - 192
[29] Hydroxycarbamide/ruxolitinibLack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 220 - 220
[30] Hydroxycarbamide/sumatriptanLack of efficacy: case report
Reactions Weekly, 2021, 1836 (1) : 373 - 373

← 1 2 3 4 5 →